or Try an Advanced Search...

    Technical Analysis for HEPA - Hepion Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 0.65 -1.38% -0.01
    HEPA closed down 1.38 percent on Friday, November 1, 2024, on 43 percent of normal volume.
    Earnings due: Nov 18
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical HEPA trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    MACD Bearish Signal Line Cross Bearish 0.00%
    Outside Day Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Down Weakness 0.00%
    20 DMA Support Bullish -1.38%
    1,2,3 Pullback Bullish Bullish Swing Setup -1.38%
    NR7 Range Contraction -1.38%
    NR7-2 Range Contraction -1.38%
    Wide Bands Range Expansion -1.38%
    Older End-of-Day Signals for HEPA ...

       Recent Intraday Alerts

    Alert Time
    Reversed from Down about 22 hours ago
    20 DMA Support about 22 hours ago
    10 DMA Resistance about 23 hours ago
    Gap Down Closed about 24 hours ago
    1,2,3, Pullback Entry about 24 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    HEPA Chart by TradingView
    Basic chart:

    Profile

    Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of pleiotropic drug therapy for the treatment of chronic liver diseases in the United States. It is involved in developing CRV431, a cyclophilin inhibitor that has completed the Phase I clinical trials for multiple biochemical pathways involved in the progression of liver diseases; and TXL, a lipid acyclic nucleoside phosphonate that delivers high intracellular concentrations of the active antiviral agent tenofovir diphosphate for the treatment of Hepatitis B. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Phosphates Hepatitis B Lipid Liver Disease Hepatotoxins Cyclophilin Drug Therapy Gilead Sciences Treatment Of Hepatitis Chronic Liver Diseases Treatment Of Hepatitis B Chronic Liver Disease Tenofovir Disoproxil

    Is HEPA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 4 Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form F-4 Related to Proposed Merger
    Jul 22 Pharma Two B Announces Plans to Go Public via Merger with Hepion Pharmaceuticals, Inc. and Concurrent $11.5 Million Private Placement
    See more HEPA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.37
    52 Week Low 0.5525
    Average Volume 43,928
    200-Day Moving Average 1.33
    50-Day Moving Average 0.70
    20-Day Moving Average 0.66
    10-Day Moving Average 0.68
    Average True Range 0.07
    RSI (14) 47.37
    ADX 30.5
    +DI 17.63
    -DI 13.94
    Chandelier Exit (Long, 3 ATRs) 0.68
    Chandelier Exit (Short, 3 ATRs) 0.77
    Upper Bollinger Bands 0.79
    Lower Bollinger Band 0.53
    Percent B (%b) 0.47
    BandWidth 38.64
    MACD Line 0.00
    MACD Signal Line 0.00
    MACD Histogram -0.0004
    Fundamentals Value
    Market Cap 2.82 Million
    Num Shares 4.34 Million
    EPS -12.42
    Price-to-Earnings (P/E) Ratio -0.05
    Price-to-Sales 0.00
    Price-to-Book 0.46
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.77
    Resistance 3 (R3) 0.77 0.72 0.75
    Resistance 2 (R2) 0.72 0.69 0.72 0.74
    Resistance 1 (R1) 0.69 0.67 0.70 0.69 0.74
    Pivot Point 0.64 0.64 0.65 0.65 0.64
    Support 1 (S1) 0.61 0.61 0.63 0.61 0.56
    Support 2 (S2) 0.56 0.59 0.57 0.56
    Support 3 (S3) 0.53 0.56 0.55
    Support 4 (S4) 0.53